Norges Bank’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
+54,219
| New | +$201K | ﹤0.01% | 1692 |
|
|
2025
Q1 | – | Sell |
-500,823
| Closed | -$2.79M | – | 595 |
|
|
2024
Q4 | $2.79M | Buy |
+500,823
| New | +$2.79M | ﹤0.01% | 1644 |
|
|
2024
Q2 | – | Sell |
-54,219
| Closed | -$1.73M | – | 1953 |
|
|
2024
Q1 | $1.73M | Buy |
+54,219
| New | +$1.73M | ﹤0.01% | 1749 |
|
|
2023
Q2 | – | Sell |
-294,000
| Closed | -$5.05M | – | 2047 |
|
|
2023
Q1 | $5.05M | Hold |
294,000
| – | – | ﹤0.01% | 1752 |
|
|
2022
Q4 | $6.53M | Buy |
+294,000
| New | +$6.53M | ﹤0.01% | 1704 |
|
|
2021
Q1 | – | Sell |
-5,000
| Closed | -$207K | – | 2154 |
|
|
2020
Q4 | $207K | Buy |
+5,000
| New | +$207K | ﹤0.01% | 2104 |
|